8 Reasons Why We’re Excited about 2012
Recent news and predictions for venture capital have been anything but cheery. With a wobbly economy and uncertainty surrounding government reforms, investors are understandably cautious.…
Posted by
Safeguard Insights
3 Tips on Valuations and Exits for Emerging Healthcare Companies
Last week, I sat on a panel session at the IMPACT 2011 Venture Summit Mid-Atlantic conference held by the Greater Philadelphia Alliance for Capital and Technologies (PACT)…
Posted by
A Focus on Life Sciences
Safeguard Scientifics has a unique and consistent approach to putting capital to work in the life sciences sector. We target capital efficient diagnostic companies that…
Posted by
Safeguard Scientifics Second Quarter 2011 Financial Results Recap
This morning, we announced our second quarter 2011 financial results and reported on the exciting progress we’ve made this quarter. We deployed $45.8 million of…
Posted by
Safeguard Scientifics Leads $35 Million Financing for NovaSom
Baltimore-based company provides home sleep tests for the diagnosis of obstructive sleep apnea Wayne, PA, June 27, 2011 – Safeguard Scientifics, Inc. (NYSE: SFE), a holding…
Posted by
Communicating Value and Increasing Transparency: Medical Devices
Changing The Standard of Care New medical devices, born of the convergence of healthcare and technology, represent a promising growth opportunity for Safeguard Scientifics. Our…
Posted by
Safeguard Scientifics Fourth Quarter and Year-End Financial Results Recap, Highlighting Aggregate Partner Company Revenue Growth, Acquisitions and IPOs
This morning, we announced our fourth quarter and year-end 2010 financial results. In 2010, our aggregate partner company revenue was $403 million, up 54 percent…
Posted by
Life Sciences Trends for 2011: Companion Diagnostics, Reimbursement and Consumerization
Last week, Safeguard Scientifics’ Life Sciences team attended J.P. Morgan’s 29th Annual Healthcare Conference and OneMedForumSF 2011 (video) in San Francisco. Our main takeaway is that…
Posted by
Video: James A. Datin Talks About Safeguard Scientifics’ Life Sciences Strategy
James A. Datin, Executive Vice President and Managing Director of Life Sciences Group at Safeguard Scientifics, discusses his thoughts on the opportunities in life sciences…
Posted by
